TP53 and endometrial cancer: Although abnormal p53 has been consistently associated with a poor prognosis in patients with endometrial cancer [17,18,19,20,21,22,23,24], there are limited data and small series specifically addressing the association between p53 status and outcomes in G3 endometrioid endometrial carcinomas.